Search research articles
Contact Us
Filters
Showing results (41-50 of 84) with videos related to
Page
of 9
Sort By:
Scientific Reports
|
December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin
Mikael Lisak, Malin Nicklasson, Robert Palmason, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2024
Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries
Niels Abildgaard, Pekka Anttila, Anders Waage, et al.
Clinical Epidemiology
|
September 25, 2023
Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma
Niels Abildgaard, Jonatan Freilich, Pekka Anttila, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2018
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Meletios A Dimopoulos, Sebastian Grosicki, Wiesław W Jędrzejczak, et al.
European Journal of Haematology
|
November 17, 2019
Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry
Göran Wålinder, Jan Samuelsson, Per Näsman, et al.
European Journal of Haematology
|
May 26, 2017
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
Hareth Nahi, Anna Genell, Göran Wålinder, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
Fredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Cancer Reports (Hoboken, N.J.)
|
March 4, 2022
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study
Göran Wålinder, Anna Genell, Gunnar Juliusson, et al.
Blood Advances
|
May 21, 2020
Search for multiple myeloma risk factors using Mendelian randomization
Molly Went, Alex J Cornish, Philip J Law, et al.
Cancer Cell
|
April 20, 2013
A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo
Niina Veitonmäki, Markus Hansson, Fenghuang Zhan, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 84) with videos related to
Sort By:
Page
of 9
Scientific Reports
|
December 20, 2023
Higher cyclosporine-A concentration increases the risk of relapse in AML following allogeneic stem cell transplantation from unrelated donors using anti-thymocyte globulin
Mikael Lisak, Malin Nicklasson, Robert Palmason, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 20, 2024
Real-world treatment patterns and outcomes for patients with multiple myeloma in Denmark, Finland and Sweden: An analysis using linked Nordic registries
Niels Abildgaard, Pekka Anttila, Anders Waage, et al.
Clinical Epidemiology
|
September 25, 2023
Use of Linked Nordic Registries for Population Studies in Hematologic Cancers: The Case of Multiple Myeloma
Niels Abildgaard, Jonatan Freilich, Pekka Anttila, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 25, 2018
All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
Meletios A Dimopoulos, Sebastian Grosicki, Wiesław W Jędrzejczak, et al.
European Journal of Haematology
|
November 17, 2019
Outcome and characteristics of non-measurable myeloma: A cohort study with population-based data from the Swedish Myeloma Registry
Göran Wålinder, Jan Samuelsson, Per Näsman, et al.
European Journal of Haematology
|
May 26, 2017
Incidence, characteristics, and outcome of solitary plasmacytoma and plasma cell leukemia. Population-based data from the Swedish Myeloma Register
Hareth Nahi, Anna Genell, Göran Wålinder, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
November 30, 2022
Cobimetinib Alone and Plus Venetoclax With/Without Atezolizumab in Patients With Relapsed/Refractory Multiple Myeloma
Fredrik Schjesvold, Bruno Paiva, Vincent Ribrag, et al.
Cancer Reports (Hoboken, N.J.)
|
March 4, 2022
Regional differences in treatment and outcome for myeloma patients in Sweden: A population based Swedish myeloma register study
Göran Wålinder, Anna Genell, Gunnar Juliusson, et al.
Blood Advances
|
May 21, 2020
Search for multiple myeloma risk factors using Mendelian randomization
Molly Went, Alex J Cornish, Philip J Law, et al.
Cancer Cell
|
April 20, 2013
A human ICAM-1 antibody isolated by a function-first approach has potent macrophage-dependent antimyeloma activity in vivo
Niina Veitonmäki, Markus Hansson, Fenghuang Zhan, et al.
Page
of 9